GHK-Cu Peptide: molecular structure, mechanisms of action and applications in scientific research

GHK-Cu is a naturally occurring copper-containing tripeptide complex that has attracted the interest of scientists due to its involvement in cellular communication, the regulation of extracellular matrix, and biological processes related to tissue maintenance and repair. Since its identification in 1973 by Lorena Pickart, researchers have analyzed its molecular structure, its ability to bind copper, its effect on gene expression, and its interaction with cellular pathways involved in inflammatory processes, oxidative stress, and tissue remodeling.

This compound was first identified during studies of human serum components and their effects on protein synthesis in cells. Pickart observed that serum-derived factor can influence the behavior of aging liver cells by stimulating protein synthesis patterns characteristic of younger cells [1]. Later studies allowed identifying the tripeptide glycyl-L-histidyl-L-lysine (GHK) and analyzing its ability to form a stable complex with divalent copper ions (Cu²⁺).

GHK consists of three amino acids: glycine, histidine, and lysine. When bound to copper(II) ion, it forms a complex commonly referred to as GHK-Cu or the copper peptide GHK.

This peptide has been detected in human biological fluids, including plasma, saliva, and urine. According to published data, its concentration in plasma decreases with age—from approximately 200 ng/mL at age 20 to approximately 80 ng/mL at age 60 [2–9]. These observations have contributed to the development of research on the relationships between GHK, cellular changes associated with aging, and the regulation of tissue processes.

Experimental studies have shown that GHK-Cu can influence collagen synthesis, extracellular matrix remodeling, angiogenic signaling, and the activity of antioxidant enzymes. In fibroblast cultures and animal models, its effects on inflammatory mediators, cell migration, and patterns of tissue remodeling-related gene expression were also analyzed.

Some analyses have linked GHK to changes in over 4,000 genes, suggesting that its biological activity may involve multiple interconnected cellular pathways [9].

Changes in gene expression do not automatically mean improved tissue function or beneficial clinical outcomes. Many observations come from cell culture studies, computer analyses, or animal experiments.

GHK-Cu therefore remains an important subject of molecular and preclinical research, particularly in the context of copper coordination, extracellular matrix biology, oxidative stress, and cell responses to injury.

What is GHK-Cu?

GHK-Cu is a coordination complex that forms when the glycyl-L-histidyl-L-lysine tripeptide binds to the copper ion. The ability to coordinate copper is one of the molecular properties that distinguishes it from many other short peptides [1, 2].

Copper is an essential trace element involved in numerous biological processes. It supports the activity of enzymes, mitochondrial energy production, antioxidant protection, and the formation and maintenance of connective tissues.

At the same time, the copper economy must be subject to strict regulation, because unbonded or improperly controlled copper can participate in reactions leading to the formation of reactive forms of oxygen.

GHK creates a molecular environment that enables the binding of copper and influences its chemical properties. Through this interaction, GHK-Cu has become a useful research model for analyzing the role of small peptides in metal coordination and cellular signaling.

Early studies focused on its effects on fibroblasts, the cells responsible for the production and maintenance of many components of connective tissue.

Fibroblasts synthesize collagen, components related to elastin, glycosaminoglycans, and other extracellular matrix molecules. These substances are responsible for the mechanical properties, organization, and structural stability of tissues.

Studies conducted by Borela, Maquart and colleagues showed that GHK-Cu can affect the metabolism of the extracellular matrix in fibroblast cultures even at concentrations of about 1–10 nanomoles per liter (nM) [10–13].

The observed effects included changes in the production and degradation of collagen, sulfated glycosaminoglycans, and small proteoglycans such as deoxycholic acid.

Importantly, maintaining the extracellular matrix requires more than just increasing the production of structural proteins.

Proper tissue regeneration is based on the coordinated synthesis, modification, and breakdown of matrix components.

Matrix metalloproteinases (MMP) are involved in the degradation of extracellular matrix, while tissue inhibitors of metalloproteinases (TIMP) help regulate their activity.

Experimental studies have shown that GHK-Cu affects MMP activity and the expression of inhibitors such as TIMP-1 and TIMP-2 [11, 12].

These observations suggest a link between exposure to GHK-Cu and changes in matrix components. However, they do not prove that this link consistently causes beneficial tissue remodeling in humans.

In additional preclinical studies, GHK-Cu was analyzed in wound models, including experiments on wound contraction, graft integration, inflammatory signaling, and cell migration [3–5].

Other studies concerned the response of fibroblasts to radiation-related damage. Changes in cell growth and viability were observed, as well as the expression of growth factors [14].

The experiments also analyzed interactions involving immune cells and endothelial cells, which are involved in the tissue response to injury [15].

Animal studies have shown changes in antioxidant activity and parameters related to wounds after exposure to GHK-Cu or materials containing related peptides [16–21].

These results have increased interest in GHK-Cu as a research tool for analyzing cellular aging, the regulation of extracellular matrix, and the tissues' response to oxidative and mechanical damage.

However, observations regarding wound closure, fibroblast behavior, or molecular signaling in experimental models should not be interpreted as evidence of therapeutic efficacy in humans.

Mechanism of action of GHK-Cu: results of in vitro and in vivo studies

The biological mechanisms associated with GHK-Cu involve several interconnected pathways, rather than a single clearly defined molecular target.

In experimental studies, its effects on gene expression, the signaling of growth factors, the metabolism of extracellular matrix, the response to oxidative stress, inflammatory pathways, and cell-cell interactions were analyzed.

These mechanisms were studied using cell culture, animal models, and computer analyses.

Expression of genes and reconstruction of lung tissue

One of the important research areas is the relationship between GHK and patterns of gene expression associated with chronic obstructive pulmonary disease (COPD).

In a multicenter study involving researchers from Boston University, the University of Groningen, the University of British Columbia, and the University of Pennsylvania, the signatures of gene expressions associated with lung tissue destruction in the course of emphysema were analyzed [22].

A group of 127 genes associated with lung fibrosis has been identified and it has been investigated whether GHK can affect abnormal transcription patterns.

The researchers noted that exposure to GHK was associated with changes in the signaling of transforming growth factor beta (TGF-β).

TGF-β is an important regulator of cell differentiation, extracellular matrix production, tissue remodeling, and fibrosis.

Its action depends on the biological context. Although TGF-β is involved in the proper maintenance of tissues, impaired signaling can also contribute to the pathological accumulation of matrix components and the development of fibrosis.

In laboratory experiments using pulmonary fibroblasts collected from patients with COPD, exposure to GHK was associated with an improvement in the ability to contract and reorganize collagen.

The researchers also noted increased expression of integrin β1, which suggests a possible involvement of integrin-dependent cellular interactions [22, 23].

Integrins are proteins that help cells interact with the extracellular matrix surrounding them. They are involved in cell adhesion and migration, the transmission of mechanical signals, and tissue organization.

These observations suggest that GHK may influence the relationships between TGF-β signaling, integrin expression, and the regulation of the extracellular matrix.

However, the experiments do not prove that GHK-Cu reverses the course of COPD or restores lung function in patients.

The results concern patterns of gene expression and cell behavior under experimental conditions.

Expression of genes related to tumors and cell proliferation

GHK has also been analyzed in studies concerning genetic networks associated with tumors.

Hong and colleagues studied the patterns of gene expression associated with the progression of colorectal cancer and its metastatic potential [7, 24].

Later interpretations of these data linked GHK with a reduction in the expression of approximately 70% selected gene groups associated with metastases.

In this context, genes MAP3K5, LMNA, APP and NFATC2 were discussed, among others.

These genes are involved in various biological processes, including intracellular signaling, the organization of the cell nucleus, cell regulation, and transcriptional responses.

However, changes in the expression of genes associated with metastases should not be equated with proven prevention of metastases.

Gene expression signatures can help identify pathways related to the course of the disease, but their modification does not constitute independent clinical evidence of anti-cancer activity.

In other laboratory studies, the exposure to GHK was analyzed in human cancer cell lines.

Changes in apoptosis and cell proliferation were observed in some experiments involving neuroblastoma and breast cancer models at nanomolar concentrations [25].

Apoptosis is a regulated form of cell death that is involved in tissue development and the maintenance of cellular homeostasis.

Apoptosis disorders are important in the biology of tumors, because malignant cells can develop mechanisms that allow them to avoid the normal signals that lead to cell death.

However, the observation of apoptosis in cultures of cancer cells does not prove selective anti-tumor activity in the human body.

Cellular lines differ from real tumors in terms of architecture, metabolism, microenvironment, interactions with the immune system, and exposure conditions.

Therefore, these results remain relevant for research on the mechanisms of carcinogenesis, rather than for confirmed applications in clinical oncology.

Fibroblast activity and remodeling of the extracellular matrix

Fibroblast studies constitute another important element of the scientific literature concerning GHK-Cu.

After exposure to complexes of copper peptides, changes in collagen production, matrix degradation, and the expression of growth factors were observed [9, 26].

The synthesis of collagen is only one of the elements of the regulation of the extracellular matrix.

In order to maintain proper tissue structure, the matrix must also undergo controlled degradation and reorganization.

GHK-Cu was associated with changes in the activity of matrix metalloproteinases and the expression of TIMP-1 and TIMP-2.

These results suggest that the compound can influence both the production and the breakdown of matrix components.

The direction and significance of these changes depend on the experimental model and the surrounding biological conditions.

In models of irradiated fibroblasts, researchers analyzed whether copper tripeptides affect cell growth and the expression of growth factors after exposure to radiation [26].

Changes in DNA repair-related pathways were also noted in the gene expression analyses discussed in the literature. These included 47 genes with increased expression and five genes whose expression decreased by at least 50% [9, 26].

These results indicate changes in the transcriptional response of cells.

However, they do not in themselves prove the complete repair of DNA, the reversal of cellular aging, or the restoration of proper tissue function.

Angiogenic signaling and growth factors

GHK-Cu was also studied in the context of angiogenesis, the process of formation of new blood vessels from already existing vascular structures.

Angiogenesis is involved in tissue development, responses to injury, and the maintenance of the blood vessel network.

Experimental studies analyzed the relationships between materials containing GHK and factors such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) [27].

VEGF is involved in endothelial cell signaling and the development of blood vessels.

The basic FGF is involved in cell proliferation and differentiation, as well as in tissue responses involving vascular and connective tissues.

In some studies, increased expression or secretion of these factors was observed after exposure to GHK-related materials.

As a possible element of these effects, signaling dependent on integrins was also discussed.

Changes in VEGF or bFGF expression do not, however, indicate the formation of functional blood vessels.

Normal angiogenesis involves many stages, including the migration of endothelial cells, the formation of blood vessels, their stabilization, and their incorporation into the existing circulatory system.

The available results therefore provide mechanistic evidence relevant to vascular research, but do not confirm the clinical benefits associated with vascular function.

Structure and biochemistry of GHK-Cu

The molecular structure of GHK-Cu was studied using various analytical and spectroscopic techniques.

They included X-ray crystallography, electron paramagnetic resonance (EPR), spectroscopy of X-ray absorption, proton magnetic resonance, and chemical labeling methods [28–30].

These methods helped characterize the coordination environment of copper in the peptide complex.

Copper coordination and molecular geometry

GHK consists of three amino acids arranged in the sequence glycine–histidine–lysine.

The rest of the histidine group is of particular importance because its imidazole group can participate in the coordination of metal ions.

Structural studies indicate that copper(II) can form coordination bonds with three nitrogen atoms that function as electron donors in the peptide molecule.

These include the nitrogen atom of the amino group of glycine, the deprotonated nitrogen atom of the amidic bond associated with the glycine–histidine bond, and the nitrogen atom of the imidazole ring of histidine [28–30].

The fourth coordination position can be occupied by another donor group, depending on the chemical environment.

This arrangement is often described as quadratic-planar geometry or as being close to quadratic-planar geometry.

The exact geometry may depend on the pH, the solvent conditions, the presence of additional ligands, and the form of the complex being studied.

The coordination of copper affects the chemical properties of GHK-Cu and distinguishes this complex from the unbound GHK peptide.

The structural dependence between the peptide and copper is important because metal binding can alter the reactivity of the molecule and its interactions with other biological compounds.

Figure: Molecular structure of the GHK-Cu complex

The molecular structure of GHK-Cu shows how the glycine-histidine-lysine peptide provides nitrogen-containing coordination sites that enable the binding of copper(II).

Structural and spectroscopic studies identified the amino group nitrogen, the amide nitrogen of the peptide bond, and the imidazole ring nitrogen of histidine as important elements involved in the copper binding.

The coordination environment helps to explain why GHK is studied as a copper-binding peptide and as a model of the interactions between metals and peptides.

Interactions with albumin and other copper-binding molecules

At physiological pH, GHK-Cu can participate in various coordination equilibria with the involvement of additional ligands.

Lau and Sarkar studied the interactions between copper(II), GHK, histidine-containing molecules, and serum albumin [28–30].

Serum albumin is a protein that is present in large quantities in the plasma. It participates in the transport and binding of many substances, including selected metal ions.

The literature describes the high affinity of both GHK and albumins for copper binding. In the tested conditions, values of approximately log₁₀ 16.44 were obtained for GHK and log₁₀ 16.2 for albumin.

These values suggest that GHK may participate in competitive interactions related to copper binding.

However, the distribution of copper in biological fluids depends on more than just the binding strength of the two isolated molecules.

The availability of copper is also influenced by the concentrations of individual substances, competing ligands, protein interactions, and cellular transport systems.

GHK's ability to bind copper thus forms the basis for research on metal transfer and coordination equilibria.

However, it does not prove that GHK-Cu safely delivers copper to all tissues or that it prevents all oxidative reactions associated with copper.

Copper-dependent enzymes and redox process regulation

Copper is essential for the activity of many important enzymes.

Lysosomal oxidase is involved in the formation of cross-links between the collagen and elastin molecules.

Copper-zinc superoxide dismutase, commonly referred to as SOD1, supports antioxidant protection by catalyzing the conversion of superoxide radicals into less reactive products.

Cytochrome c oxidase is involved in mitochondrial electron transport and the production of cellular energy.

Because GHK binds to copper, scientists examined whether GHK-Cu could affect the availability of this metal and the biochemical processes associated with it.

The presence of the copper-binding peptide does not, however, mean that the metal is directly transferred to every copper-dependent enzyme.

Cells possess specialized transporters, binding proteins, and regulatory systems for intracellular copper distribution.

These mechanisms are important because free or improperly regulated copper can participate in oxidation reactions.

Under certain conditions, redox reactions involving copper can contribute to the formation of reactive chemical forms.

Therefore, GHK-Cu was studied with regard to its potential effect on copper reactivity and oxidative processes [31, 32].

This dependence is complex in terms of chemistry. Copper binding can alter the reactivity of the metal, but the biological consequences depend on the entire chemical environment.

Bonding of aldehydes and oxidative chemistry

GHK was also studied for its ability to react with selected aldehydes produced during lipid peroxidation.

Lipid peroxidation involves oxidation reactions that affect the lipids of cell membranes and other structures containing lipids.

As a result of these reactions, reactive aldehydes such as 4-hydroxybenzene and acrolein can form.

Both compounds are the subject of research because they can interact with proteins and other cellular molecules.

Chemical studies have shown that GHK can form reaction products with these aldehydes, suggesting a potential ability of these compounds to bind in experimental conditions [31, 32].

These results provide information about the chemical reactivity of GHK.

However, the ability to react with aldehydes in the laboratory system does not prove that the peptide prevents oxidative damage to tissues in humans.

Reagent concentrations, the presence of competing biological molecules, and the reaction rate are important in assessing potential biological consequences.

Cell adhesion and interactions with the extracellular matrix

GHK-Cu was also studied in the context of cell adhesion and their interaction with extracellular materials.

Cell adhesion is essential for proper tissue organization, because cells must recognize the surrounding environment and interact with it.

In studies involving osteoblastic cells and hepatocyte adhesion models, the effects of GHK-related materials on the spread of cells, their adhesion, and phenotype were analyzed [33, 34].

These studies are important for the development of biomaterials in which peptides can be embedded into or attached to engineering surfaces.

The observed effects depend on the type of peptide, the composition of the material, the type of cells, and the experimental conditions.

They provide information about the interactions between peptides and surfaces, and between cells and the matrix, rather than direct evidence of tissue regeneration in humans.

Applications of GHK-Cu in scientific research

GHK-Cu has been studied in many areas of molecular and preclinical research.

They include oxidative stress biology, inflammatory signaling, fibrosis, lung damage, neuronal responses, vascular regulation, remodeling of the extracellular matrix, and analysis of gene expression.

The following sections present the most important experimental results and their limitations.

Studies on antioxidant activity and redox processes

Copper-dependent antioxidant enzymes are an important component of cellular protection against oxidative stress.

One example is SOD1, which requires copper and zinc for proper function.

Studies on copper deficiency have shown that its insufficient availability can affect the activity of SOD1 and increase the values of parameters related to oxidative stress [35–38].

These results confirm the biological significance of proper regulation of the copper economy.

However, studies on copper deficiency or the restoration of its supply in the diet cannot be automatically considered evidence of identical action of GHK-Cu.

Distinguishing is important because the biological behavior of a specific copper complex depends on its molecular structure, distribution, and interactions with the pathways regulating the metabolism of this metal.

In experimental studies involving biomaterials containing GHK and copper tripeptide complexes, antioxidant responses and tissue-related parameters were analyzed.

Part of the research concerned whether GHK-Cu affects lipid peroxidation associated with ferrytyl.

Feritine is a protein involved in intracellular iron storage.

Iron can participate in oxidation reactions when it is present in reactive forms.

Studies have shown that copper coordinated with GHK can affect ferritin-dependent lipid peroxidation under certain experimental conditions [39, 40].

These observations provide information about the interactions between copper complexes, processes related to iron, and the chemistry of oxidative reactions.

Additional chemical studies analyzed the reactions of GHK with lipid peroxidation products, such as 4-hydroxybenzoate and acrolein [41, 42].

The results justify further research on GHK as a molecule capable of participating in chemical reactions with aldehydes.

However, the antioxidant activity demonstrated in the chemical test or cell model does not prove clinical protection against oxidative damage.

Inflammatory signaling and cytokine regulation

The inflammatory state involves coordinated interactions between immune cells, signaling proteins, and tissue reactions.

In several laboratory studies, the effect of GHK-Cu on inflammatory pathways was analyzed.

In cellular studies using RAW 264.7 macrophage-like cells and Caco-2 intestinal epithelial cells, changes in oxidative and inflammatory parameters were observed after exposure to GHK-Cu.

They included a reduction in the production of reactive oxygen species, an increase in antioxidant parameters related to glutathione, and changes in inflammatory mediators such as TNF-α and IL-6 [43–47].

The researchers also analyzed signaling pathways involving the nuclear factor kappa B (NF-kB) and the protein kinase activated by mitogens p38 (p38 MAPK).

NF-κB participates in the regulation of genes related to inflammation, immunity, cell survival, and stress response.

The p38 MAPK pathway is involved in cellular responses related to inflammatory mediators and environmental stress.

In experimental studies, GHK-Cu was associated with changes in the signaling pathways of NF-κB p65 and p38 MAPK.

These results suggest that the compound may influence pathways involved in the inflammatory response under laboratory conditions.

However, not all the studies cited in the broader discussion directly evaluate GHK-Cu. Some publications present general information about inflammatory pathways or other experimental compounds.

Therefore, the mere existence of studies on NF-κB or p38 MAPK does not prove that GHK-Cu causes a specific anti-inflammatory clinical effect.

These results are most useful for understanding possible molecular interactions and identifying issues that require further experiments.

Models of fiberization, lung damage and neuroprotection

Fibrosis involves the abnormal accumulation or organization of extracellular matrix components in tissues.

It may develop in response to ongoing damage, inflammation, or altered cellular signaling.

GHK was studied in experimental lung fibrosis models due to its reported effects on fibroblast activity and the pathways associated with TGF-β.

In a mouse model of pulmonary fibrosis induced by bleomycin, researchers observed changes in tissue thickness, inflammation-induced cell crowding, and pathways associated with the epithelial-mesenchymal transition [48].

The study analyzed the signaling of TGF-β1/Smad, which is involved in cellular responses related to matrix formation and fiber formation.

These observations suggest that GHK may influence selected fiber-related pathways in animal experiments.

However, the effect obtained in the chemically induced mouse model of the disease does not prove efficacy in the treatment of pulmonary fibrosis in humans.

Biological mechanisms, the course of the disease, and clinical circumstances can vary significantly.

Neurobiological studies involving GHK also analyzed oxidative stress, inflammatory signaling, and possible interactions with gene regulatory pathways.

Some studies link these mechanisms to histone deacetylase 2 (HDAC2), an enzyme involved in chromatin regulation and gene expression.

However, the cited literature on cognitive changes in aging mice and mechanisms related to HDAC also includes studies that do not directly confirm the effects specific to GHK-Cu [49].

Therefore, claims regarding improved cognitive function, reduced neuroinflammation, or direct regulation of HDAC2 by GHK-Cu require a clear separation from the results of studies on other experimental interventions.

Available evidence supports the interest in mechanistic studies, but does not confirm established neuroprotective effects in humans.

Observations in models of angiogenesis and vascular biology

Angiogenesis is an essential process in the development and repair of tissues.

It involves the formation of new blood vessels and requires coordinated interactions between endothelial cells, growth factors, extracellular matrix components, and surrounding tissues.

GHK-Cu was studied in experimental systems related to vascular signaling and tissue regeneration.

Changes in angiogenic factors have been observed in some studies, including VEGF and bFGF [50, 51].

These proteins are involved in endothelial cell activity, the development of blood vessels, and the cellular response to injury.

The researchers also analyzed the relationships between the compounds associated with GHK and structural proteins such as collagen and elastin.

Collagen is responsible for the strength of tissues, while elastin supports their ability to stretch and return to their original shape.

Both proteins are important for the structure of blood vessels and the organization of the extracellular matrix.

Changes in the expression of growth factors or the synthesis of maternal proteins do not, however, necessarily mean an improvement in blood flow.

Functional vessel reconstruction involves additional processes, including vessel formation, maturation, integration, and physiological regulation.

In some broader studies on vessel regeneration, the anti-thrombotic and vasodilatory effects are also mentioned.

These are separate physiological processes and it should not be assumed that they result directly from exposure to GHK-Cu without adequate evidence regarding this particular compound.

The current results remain therefore of importance primarily for experimental studies on angiogenesis and vascular biology.

Evidence from neuronal and neurotrophic models

The development and repair of neurons involve the participation of growth factors, interactions with the extracellular matrix, cell migration, and the elongation of neuronal processes.

The increase in neurons is one of the experimental parameters used to study differentiation and development of neurons.

In early studies using neural tissue culture, the effect of conditioned peptides and nutrients on neuron differentiation was analyzed [52, 53].

These studies contributed to a broader interest in short peptides as potential regulators of cell behavior.

Materials related to GHK were also analyzed in experimental nerve regeneration systems.

In one study, a peptide that supports cell adhesion to collagenous guidewires used to connect interrupted sections of nerves was introduced [54].

Scientists noted changes in growth factors and inflammatory mediators, including nerve growth factor (NGF) and neurotrophins NT-3 and NT-4.

Additional observations included axon parameters and responses of Schwann cells.

Schwanna cells are an important component of the peripheral nervous system. They support axons and participate in the response to damage to peripheral nerves.

However, the results obtained using collagen-containing peptides should not be automatically attributed to the freely circulating GHK-Cu.

The observed effects may be influenced by the biomaterial, the local environment, the way the peptide is presented, and the experimental model used.

Similarly, increasing the expression of growth factors or the number of axons in the experimental system does not prove functional neurological regeneration in humans.

These studies can best be interpreted as analyses of biomaterials containing peptides and neurotrophic signaling.

Gene regulation and the reconstruction of the mother cell

The study of gene expression has become an important element of the scientific discussion regarding GHK and GHK-Cu.

Early experiments focused on cellular responses related to wounds, including fibroblast behavior, collagen production, and the organization of extracellular matrix [55, 56].

Subsequent studies by Maquart and colleagues analyzed the effect of GHK-Cu on collagen synthesis and matrix-related molecules [57–59].

In experiments using fibroblast cultures, changes in collagen production were observed at low concentrations.

In other studies, sulfated glycosaminoglycans and small proteoglycans were analyzed.

These molecules participate in the organization of the extracellular matrix, maintaining hydration, shaping mechanical properties, and interactions between cells and surrounding tissues.

GHK-Cu has also been associated with changes in the expression of matrix metalloproteinases, including MMP-2 [59].

This is important because maintaining the extracellular matrix requires both controlled degradation and synthesis.

Just increasing collagen production does not prove an improvement in tissue organization.

Similarly, increased MMP activity can lead to various consequences depending on the type of tissue and the biological context.

Research therefore suggests that GHK-Cu may influence placental development through several interacting pathways.

However, these observations do not support the concept of healing without scarring or predictable tissue regeneration in humans.

In additional experiments, changes were observed in molecules such as decanoic acid, dermatan sulfate, and chondroitin sulfate [60].

Dekorine is a small proteoglycan associated with collagen organization and the regulation of the extracellular matrix.

Dermatan sulfate and chondroitin sulfate are glycosaminoglycans that affect the structure and properties of connective tissues.

Changes in their expression or synthesis provide information about the mother's metabolism.

However, they do not independently demonstrate improvements in tissue strength, appearance, or clinical healing outcomes.

Expression of integrin and studies of epidermis cells

Keratinocytes are the predominant type of epidermis cells.

They participate in the formation of the skin barrier, cellular differentiation, and the response to tissue damage.

Researchers from Seoul National University studied the effect of copper peptide GHK on the expression of integrins and the presence of cells exhibiting positive p63 expression in keratinocytes [61].

Integrins are involved in cell adhesion and communication with the extracellular matrix.

Protein p63 is associated with the development of the epithelium and the maintenance of specific populations of epithelial cells.

The study noted increased expression of integrins and a higher percentage of cells positive for p63 after exposure to the copper peptide GHK.

These observations suggest a possible influence on cellular characteristics related to the maintenance of the epidermis.

However, changes in these markers do not in themselves indicate increased skin regeneration in humans.

The results remain limited to the cellular models used and the parameters analyzed.

Large-scale profiling of gene expression

Computer methods have increased the ability to analyze the impact of various compounds on the networks of gene expression.

The Connectivity Map, often abbreviated as cMap, is a research resource used to compare patterns of gene expression associated with biological states and chemical exposure.

Related computer approaches, including MANTRA, were used to investigate the relationship between associations and transcriptional responses [62, 63].

GHK was discussed in this context due to its connections with extensive changes in gene expression patterns.

In one of the analyses, 268 genes with increased expression and 167 genes with decreased expression were noted.

In other studies, GHK has been associated with changes involving a larger number of genes and pathways [9, 62–64].

These results suggest that responses related to GHK may involve multiple biological systems, rather than a single molecular target.

However, the data sets concerning gene expression require careful interpretation.

Changes in the amount of RNA (mRNA) information do not necessarily lead to a corresponding change in protein concentration or biological function.

The patterns of gene expression also depend on the type of cells, the exposure conditions, the measurement methods, and the analytical thresholds.

Therefore, the numbers of genes associated with a given compound should not be considered as a direct measure of its therapeutic efficacy.

Computer predictions are valuable in formulating hypotheses, but they require experimental confirmation.

Genetic networks related to neuroprotection

Analyses of gene expression discussed in the literature regarding GHK identified changes involving genes related to neuron function, cell survival, and developmental signaling.

Examples include SIGMAR1, EPM2A, NAIP, FGFR2 and SLIT2 [65].

These genes participate in various biological processes.

SIGMAR1 encodes the sigma-1 receptor, a protein involved in cellular signaling and stress-related processes.

EPM2A is associated with laforin, a protein essential for glycogen metabolism.

NAIP participates in pathways related to cell survival and immune response.

FGFR2 encodes a receptor involved in the signaling of fibroblast growth factor.

SLIT2 participates in developmental processes related to cell direction and migration.

The role of these genes in the neurobiology of the nervous system has sparked interest in their possible relationship with the transcriptional responses induced by GHK.

However, the presence of the gene in the dataset associated with GHK does not prove that GHK directly controls this gene in every biological environment.

It also does not prove that GHK prevents dementia or leads to improved neurological function.

The cited studies concerning parts of these genes provide a broader biological context, rather than direct evidence of the action of GHK-Cu.

Therefore, these results should be understood as observations that serve to formulate hypotheses regarding gene regulation and neurobiology.

Results of epigenetic studies and pathways related to HDAC

Epigenetic regulation involves changes in gene activity that do not require modification of the basic DNA sequence.

One of the important mechanisms is the modification of histones.

Histones are proteins around which DNA is organized. Their chemical modifications can affect the availability of specific regions of DNA for the transcriptional apparatus.

Histone deacetylases (HDACs) remove acetyl groups from histones and other protein substrates.

Their activity can affect the structure of chromatin and the expression of genes.

GHK was discussed in the context of HDAC-related pathways due to broader observations regarding gene regulation and age-related transcriptional changes [66, 67].

However, the cited studies on HDAC and epigenetic aging primarily provide general information about these biological processes.

They do not in themselves prove that GHK-Cu is a clinically confirmed HDAC inhibitor.

Similarly, changes in gene expression patterns should not be automatically described as an inverse of epigenetic aging.

Direct claims of HDAC inhibition require experiments demonstrating an effect on the activity of these enzymes under specific conditions.

Claims regarding reversing aging require additional evidence linking molecular measurements with significant biological results.

The relationships between GHK, chromatin regulation, and the expression of genes associated with aging therefore remain an area of further mechanistic research.

Quality and testing of GHK-Cu materials intended for scientific research

The analytical characteristics of GHK-Cu are important because the results of the tests depend on the identity, composition, and quality of the material being analyzed.

The preparation referred to as GHK-Cu should be evaluated using methods that allow the characterization of the peptide component and the provision of evidence regarding its copper-related form.

The quality analysis may include chromatography, mass spectrometry, analysis of metal content, and additional techniques selected for a specific analytical purpose.

However, no single routine test confirms all the important quality parameters.

Liquid chromatography coupled with mass spectrometry

Liquid chromatography coupled with mass spectrometry (LC-MS) combines chromatographic separation with mass spectrometry based detection of ions.

The chromatographic part allows the separation of the compounds present in the sample.

The mass spectrometer provides information about ions based on their mass ratio to charge.

LC-MS can support the identification of a peptide by detecting molecular ions consistent with the expected compound.

Depending on the method used, additional information about fragmentation can help characterize the peptide sequence.

However, the observation of a molecular mass consistent with GHK does not independently confirm all aspects of the molecule's structure.

Similarly, the detection of signals consistent with the presence of a copper-related form does not necessarily prove the complete coordination geometry or rule out all alternative complexes.

The characterization of copper binding may require additional studies using appropriate spectroscopic methods or analysis of metal content.

LC-MS is therefore a valuable analytical tool, but the reliability of the conclusions obtained depends on the method, reference patterns, sample preparation, and supporting evidence.

High-performance liquid chromatography and purity

High-performance liquid chromatography (PLHPLC) is commonly used to separate the components of peptide preparations.

It can help identify impurities related to synthesis, degradation, or other production processes.

The chromatographic purity result is usually based on the relative signals detected under specific analytical conditions.

However, chromatographic purity is not the same as chemical identity, peptide content, stoichiometry of the copper complex, or the overall quality of the material.

For example, declared purity of 98% does not necessarily mean that 98% of the total sample mass represents a properly formed GHK-Cu complex.

The interpretation depends on the analytical method used and the way the result is calculated.

The chromatogram also does not confirm sterility, endotoxin content, or the absence of all possible impurities.

The source material describes the declared purity specification of at least 98% for the specific research preparations.

Such a specification should be considered a declaration by the supplier, unless it is supported by available analytical documentation regarding a specific batch.

Filtration, sterility and control of impurities by solid particles

The source material describes the filtration through membranes with a pore size of 0.22 micrometers as an element of the material preparation process.

Membrane filtration can be used to limit certain microbiological contaminants, if the method and conditions are appropriate.

However, the passage of the solution through a 0.22 µm filter does not in itself confirm the sterility of the final product.

Ensuring sterility depends on the entire process, including equipment, the environment, the integrity of the filter, the handling of the material, and validated control procedures.

Filtration also does not have to remove endotoxins, dissolved chemical pollutants, or all types of pollutants as solid particles.

Therefore, claims regarding sterility or suitability for a specific research application require appropriate testing and documentation, rather than relying solely on the pore size of the filter.

Good Laboratory Practice and documentation

Good Laboratory Practice (GLP) is a quality system related to the organization, conduct, monitoring, documentation, and reporting of specific non-clinical studies.

The statement that procedures comply with GLP principles does not necessarily mean that they are formally compliant with GLP requirements or that they have an appropriate certificate.

The significance of such a declaration depends on the specific procedures, documentation, and quality system used.

The research materials may also be accompanied by a Certificate of Analysis (COA).

The COA usually contains selected results of analyses concerning a specific batch.

Important information may include identity testing, purity measurements, the determination of the content of substances, the analytical methods used, batch identifiers, and other specification parameters.

However, the informational value of a COA depends on the methods and data that form the basis for its issuance.

The certificate itself does not prove that the material is suitable for human consumption, cosmetic or therapeutic use.

Similarly, analytical purity does not confirm biological efficacy or clinical safety.

In scientific research, the most useful qualitative documentation should be detailed, identifiable, and sufficiently complete to enable proper interpretation of analytical results.

More information about the differentiation of producers, suppliers, quality declarations and batch documentation can be found in the article Manufacturers and suppliers of peptides.

Summary

GHK-Cu is a naturally occurring copper-containing tripeptide complex that has been studied for more than five decades.

Its molecular structure, copper binding properties, and interactions with cellular systems have made it an important subject of research in peptide biochemistry, extracellular matrix biology, oxidative stress, and gene regulation.

The complex is formed from glycyl-L-histidyl-L-lysine and copper(II). Structural studies have allowed identifying coordination sites containing nitrogen that participate in the binding of copper and influence the chemical properties of the molecule.

These characteristics provide the basis for analyzing the effects of short peptides on metal ions and the influence of coordination chemistry on biological processes.

Experimental studies have noted changes in collagen synthesis, glycosaminoglycan production, matrix metalloproteinase expression, integrin signaling, inflammatory mediators, and parameters related to antioxidant protection.

Additional studies included responses related to GHK in fibroblast cultures, wound models, experiments involving lung damage, neuronal systems, and biomaterials containing peptides.

Computer analyses also linked GHK to extensive changes in the network of gene expression.

The scientific significance of these observations depends, however, on the experimental context.

Changes in gene expression do not necessarily lead to changes in protein activity.

Increased collagen production does not necessarily mean an improvement in tissue structure.

Changes in inflammatory markers do not constitute independent clinical evidence of anti-inflammatory activity.

Similarly, the results of studies involving cancer cell lines, lung fibrosis models, or neuron cultures do not demonstrate efficacy against the corresponding diseases in humans.

There are also significant differences in the literature between GHK and GHK-Cu, and between experiments directly concerning the given compound and studies providing only a general biological context.

These distinctions should be kept in mind when interpreting the mechanisms of action and the proposed applications.

Another important issue is the analytical quality. Techniques such as LC-MS and HPLC can provide valuable information about identity and purity, but they do not independently confirm all the structural, microbiological, and biological properties of the preparation.

Overall, GHK-Cu remains a useful tool for molecular studies of copper coordination, cellular signaling, extracellular matrix metabolism, and oxidative stress response.

Its known chemical properties and extensive preclinical literature form the basis for further scientific research. However, claims regarding clinical efficacy and safety require separate, appropriately controlled human studies.

Disclaimer

This article is purely educational and scientifically informative. It presents studies concerning the molecular structure of GHK-Cu, copper coordination, biological mechanisms, analytical characteristics, and experimental applications.

It does not constitute medical advice, does not recommend the use of GHK-Cu in humans or animals, does not prescribe treatment regimens, and does not support any diagnostic, therapeutic, or cosmetic use.

The results obtained from cell cultures, animal experiments, computer analyses, and biochemical studies should not be interpreted as evidence of clinical efficacy or safety in humans.

Information regarding the analytical purity, research-grade materials, analysis certificates or laboratory tests does not prove that the product in question is suitable for human use or any other use regulated by law.

All medical decisions should be made by appropriately qualified healthcare workers based on appropriate clinical evidence and applicable regulations.

References

1. Pickart L. A Tripeptide from Human Serum Which Enhances the Growth of Neoplastic Hepatocytes and the Survival of Normal Hepatocytes. San Francisco, Calif, USA: University of California; 1973.
2. Pickart L., Freedman J. H., Loker W. J., et al. Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells. Nature. 1980;288(5792):715–717. doi: 10.1038/288715a0.
3. Pickart L. Use of GHL-Cu as a wound-healing and anti-inflammatory agent. 1988, http://www.freepatentsonline.com/4760051.html.
4. Downey D., Larrabee W. F., Jr., Voci V., Pickart L. Acceleration of wound healing using glycyl-histidyl-lysine copper (II) Surgical Forum. 1985;25:573–575.
5. Pickart L. Iamin: a human growth factor with multiple wound-healing properties. In: Sorenson J., editor. Biology of Copper Complexes. Clifton, NJ, USA: Humana Press; 1987. pp. 273–285.
6. Meiners S., Eickelberg O. Next-generation personalized drug discovery: the tripeptide GHK hits center stage in chronic obstructive pulmonary disease. Genome Medicine. 2012;4(8, article 70) doi: 10.1186/gm371.
7. Hong Y., Downey T., Eu K. W., Koh P. K., Cheah P. Y. A ‘metastasis-prone’ signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clinical and Experimental Metastasis. 2010;27(2):83–90. doi: 10.1007/s10585-010-9305-4.
8. Gruchlik A., Jurzak M., Chodurek E. W., Dzierzewicz Z. Effect of Gly-Gly-His, Gly-His-Lys and their copper complexes on TNF-α-dependent IL-6 secretion in normal human dermal fibroblasts. Acta Poloniae Pharmaceutica. 2012;69(6):1303–1306.
9. Pickart L., Vasquez-Soltero J. M., Margolina A. GHK and DNA: resetting the human genome to health. BioMed Research International. 2014;2014:10. doi: 10.1155/2014/151479.151479
10. Wegrowski Y., Maquart F. X., Borel J. P. Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex Glycyl-L-histidyl-L-lysine-Cu2+. Life Sciences. 1992;51(13):1049–1056. doi: 10.1016/0024-3205(92)90504-i.
11. Siméon A., Emonard H., Hornebeck W., Maquart F.-X. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sciences. 2000;67(18):2257–2265. doi: 10.1016/s0024-3205(00)00803-1.
12. Ehrlich H. Stimulation of skin healing in immunosuppressed rats. Proceedings of the Symposium on Collagen and Skin Repair; September 1991; Reims, France.
13. Siméon A., Wegrowski Y., Bontemps Y., Maquart F.-X. Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. Journal of Investigative Dermatology. 2000;115(6):962–968. doi: 10.1046/j.1523-1747.2000.00166.x.
14. McCormack M. C., Nowak K. C., Koch R. J. The effect of copper tripeptide and tretinoin on growth factor production in a serum-free fibroblast model. Archives of Facial Plastic Surgery. 2001;3(1):28–32.
15. Buffoni F., Pino R., Dal Pozzo A. Effect of tripeptide-copper complexes on the process of skin wound healing and on cultured fibroblasts. Archives Internationales de Pharmacodynamie et de Therapie. 1995;330(3):345–360.
16. Gul N. Y., Topal A., Cangul I. T., Yanik K. The effects of topical tripeptide copper complex and helium-neon laser on wound healing in rabbits. Veterinary Dermatology. 2008;19(1):7–14. doi: 10.1111/j.1365-3164.2007.00647.x.
17. Cangul I. T., Gul N. Y., Topal A., Yilmaz R. Evaluation of the effects of topical tripeptide-copper complex and zinc oxide on open-wound healing in rabbits. Veterinary Dermatology. 2006;17(6):417–423. doi: 10.1111/j.1365-3164.2006.00551.x.
18. Pickart L. Method of using copper(II) containing compounds to accelerate wound healing. 1992, http://www.freepatentsonline.com/5164367.html.
19. Arul V., Kartha R., Jayakumar R. A therapeutic approach for diabetic wound healing using biotinylated GHK-incorporated collagen matrices. Life Sciences. 2007;80(4):275–284. doi: 10.1016/j.lfs.2006.09.018.
20. Canapp S. O., Jr., Farese J. P., Schultz G. S., et al. The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Veterinary Surgery. 2003;32(6):515–523. doi: 10.1111/j.1532-950X.2003.00515.x.
21. Swaim S. F., Vaughn D. M., Kincaid S. A., et al. Effect of locally injected medications on healing of pad wounds in dogs. American Journal of Veterinary Research. 1996;57(3):394–399.
22. Campbell J. D., McDonough J. E., Zeskind J. E., et al. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Medicine. 2012;4, article 67 doi: 10.1186/gm367.
23. Boo S., Dagnino L. Integrins as modulators of transforming growth factor beta signaling in dermal fibroblasts during skin regeneration after injury. Advances in Wound Care. 2013;2(5):238–246. doi: 10.1089/wound.2012.0394.
24. Lubick K., Radke M., Jutila M. Securinine, a GABAA receptor antagonist, enhances macrophage clearance of phase II C. burnetii: comparison with TLR agonists. Journal of Leukocyte Biology. 2007;82(5):1062–1069. doi: 10.1189/jlb.0407255.
25. Matalka L. E., Ford A., Unlap M. T. The tripeptide, GHK, induces programmed cell death in SH-SY5Y neuroblastoma cells. Journal of Biotechnology & Biomaterials. 2012;2, article 144 doi: 10.4172/2155-952X.1000144.
26. Pollard J. D., Quan S., Kang T., Koch R. J. Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts. Archives of Facial Plastic Surgery. 2005;7(1):27–31. doi: 10.1001/archfaci.7.1.27.
27. Jose S., Hughbanks M. L., Binder B. Y. K., Ingavle G. C., Leach J. K. Enhanced trophic factor secretion by mesenchymal stem/stromal cells with Glycine-Histidine-Lysine (GHK)-modified alginate hydrogels. Acta Biomaterialia. 2014;10(5):1955–1964. doi: 10.1016/j.actbio.2014.01.020.
28. Lau S. J., Sarkar B. The interaction of copper(II) and glycyl-L-histidyl-L-lysine, a growth-modulating tripeptide from plasma. Biochemical Journal. 1981;199(3):649–656. doi: 10.1042/bj1990649.
29. Perkins C. M., Rose N. J., Weinstein B., Stenkamp R. E., Jensen L. H., Pickart L. The structure of a copper complex of the growth factor glycyl-L-histidyl-L-lysine at 1.1 Å resolution. Inorganica Chimica Acta. 1984;82(1):93–99. doi: 10.1016/s0020-1693(00)82544-x.
30. Freedman J. H., Pickart L., Weinstein B., Mims W. B., Peisach J. Structure of the glycyl-L-histidyl-L-lysine-copper(II) complex in solution. Biochemistry. 1982;21(19):4540–4544. doi: 10.1021/bi00262a004.
31. Pickart L., Lovejoy S. Biological activity of human plasma copper-binding growth factor glycyl-l-histidyl-l-lysine. Methods in Enzymology. 1987;147:314–328. doi: 10.1016/0076-6879(87)47121-8.
32. Beretta G., Arlandini E., Artali R., Anton J. M. G., Maffei Facino R. Acrolein sequestering ability of the endogenous tripeptide glycyl-histidyl-lysine (GHK): characterization of conjugation products by ESI-MSn and theoretical calculations. Journal of Pharmaceutical and Biomedical Analysis. 2008;47(3):596–602. doi: 10.1016/j.jpba.2008.02.012.
33. Godet D., Marie P. J. Effects of the tripeptide glycyl-L-histidyl-L-lysine copper complex on osteoblastic cell spreading, attachment and phenotype. Cellular and Molecular Biology (Noisy-le-Grand, France) 1995;41(8):1081–1091.
34. Kawase M., Miura N., Kurikawa N., et al. Immobilization of tripepride growth factor glycyl-L-histidyl-L-lysine on poly(vinylalcohol)-quarternized stilbazole (PVA-SbQ) and its use as a ligand for hepatocyte attachment. Biological and Pharmaceutical Bulletin. 1999;22(9):999–1001. doi: 10.1248/bpb.22.999.
35. Lutsenko S, Bhattacharjee A, Hubbard AL. Copper handling machinery of the brain. Metallomics. 2010;2(9):596–608. doi: 10.1039/c0mt00006j.
36. Hawk SN, Lanoue L, Keen CL, Kwik-Uribe CL, Rucker RB, Uriu-Adams JY. Copper-deficient rat embryos are characterized by low superoxide dismutase activity and elevated superoxide anions. Biology of Reproduction. 2003;68(3):896–903. doi: 10.1095/biolreprod.102.009167.
37. Bayer TA, Schäfer S, Simons A, et al. Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(24):14187–14192. doi: 10.1073/pnas.2332818100.
38. Arul V, Gopinath D, Gomathi K, Jayakumar R. GHK peptide incorporated collagenous matrix: a novel biomaterial for dermal wound healing in rats. Journal of Biomedical Materials Research. 2005;73(2):383–391. doi: 10.1002/jbm.b.30246.
39. Miller DM, DeSilva D, Pickart L, Aust SD. Effects of glycyl-histidyl-lysyl chelated Cu(II) on ferritin-dependent lipid peroxidation. Advances in Experimental Medicine and Biology. 1990;264:79–84. doi: 10.1007/978-1-4684-5730-8_11.
40. Alberghina M, Lupo G, La Spina G, et al. Cytoprotective effect of copper(II) complexes against ethanol-induced damage to rat gastric mucosa. Journal of Inorganic Biochemistry. 1992;45(4):245–259. doi: 10.1016/0162-0134(92)84013-d.
41. Beretta G, Artali R, Regazzoni L, Panigati M, Facino RM. Glycyl-histidyl-lysine (GHK) is a quencher of α,β-4-hydroxy-trans-2-nonenal: a comparison with carnosine. Insights into the mechanism of reaction by electrospray ionization mass spectrometry, 1H NMR, and computational techniques. Chemical Research in Toxicology. 2007;20(9):1309–1314. doi: 10.1021/tx700185s.
42. Beretta G, Arlandini E, Artali R, Anton JM, Maffei Facino R. Acrolein sequestering ability of the endogenous tripeptide glycyl-histidyl-lysine (GHK): characterization of conjugation products by ESI-MSn and theoretical calculations. Journal of Pharmaceutical and Biomedical Analysis. 2008;47(3):596–602. doi: 10.1016/j.jpba.2008.02.012.
43. Park JR, Lee H, Kim SI, et al. The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice. Oncotarget, 2016, 7(36): 58405.
44. Gao M, Chen L, Yu H, et al. Diosgenin downregulates NF-κB p65/p50 and p38MAPK pathways and attenuates acute lung injury induced by lipopolysaccharide in mice. International immunopharmacology, 2013, 15(2): 240–245.
45. Liu T, Zhang L, Joo D, et al. NF-κB signaling in inflammation. Signal transduction and targeted therapy, 2017, 2(1): 1–9.
46. Kaminska B MAPK signaling pathways as molecular targets for anti-inflammatory therapy—from molecular mechanisms to therapeutic benefits. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 2005, 1754(1–2): 253–262.
47. Yong HY, Koh MS, Moon A. The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer. Expert opinion on investigational drugs, 2009, 18(12): 1893–1905.
48. Zhou XM, Wang GL, Wang XB, et al. GHK peptide inhibits bleomycin-induced pulmonary fibrosis in mice by suppressing TGFβ1/Smad-mediated epithelial-to-mesenchymal transition. Frontiers in Pharmacology, 2017, 8: 904.
49. Mukherjee K, Lee A, Zhu L, et al. Sleep-deprived cognitive impairment in aging mice is alleviated by rapamycin. Aging Pathobiology and Therapeutics, 2019, 1(1): 05–09.
50. Kalaria RN. Vascular basis for brain degeneration: Faltering controls and risk factors for dementia. Nutrition Reviews. 2010;68(supplement 2):S74–S87. doi: 10.1111/j.1753-4887.2010.00352.x.
51. Pollard JD, Quan S, Kang T, Koch RJ. Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts. Archives of Facial Plastic Surgery. 2005;7(1):27–31. doi: 10.1001/archfaci.7.1.27.
52. Sensenbrenner M, Jaros GG, Moonen G, Meyer BJ. Effect of conditioned media on nerve cell differentiation. Experientia. 1980;36(6):660–662. doi: 10.1007/BF01970123.
53. Lindner G, Grosse G, Halle W, Henklein P. The effect of a synthetic tripeptide cultured in vitro on nervous tissue. Zeitschrift für Mikroskopisch-Anatomische Forschung. 1979;93(5):820–828. (Ger).
54. Ahmed MR, Basha SH, Gopinath D, Muthusamy R, Jayakumar R. Initial upregulation of growth factors and inflammatory mediators during nerve regeneration in the presence of cell adhesive peptide-incorporated collagen tubes. Journal of the Peripheral Nervous System. 2005;10(1):17–30. doi: 10.1111/j.1085-9489.2005.10105.x.
55. Pickart L. Use of GHL-Cu as a wound-healing and anti-inflammatory agent. United States Patent 4,760,051, July 1988.
56. Downey D, Larrabee WF, Voci V, Pickart L. Acceleration of wound healing using glycyl-histidyl-lysyl Cu(II) Surgical Forum. 1985;36:573–575.
57. Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycl-L-histidyl-L-lysine-Cu2+. FEBS Letters. 1988;238(2):343–346. doi: 10.1016/0014-5793(88)80509-x.
58. Wegrowski Y, Maquart FX, Borel JP. Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. Life Sciences. 1992;51(13):1049–1056. doi: 10.1016/0024-3205(92)90504-i.
59. Siméon A, Emonard H, Hornebeck W, Maquart FX. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sciences. 2000;67(18):2257–2265. doi: 10.1016/s0024-3205(00)00803-1.
60. Siméon A, Wegrowski Y, Bontemps Y, Maquart FX. Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. Journal of Investigative Dermatology. 2000;115(6):962–968. doi: 10.1046/j.1523-1747.2000.00166.x.
61. Kang YA, Choi HR, Na JI, et al. Copper-GHK increases integrin expression and p63 positivity by keratinocytes. Archives of Dermatological Research. 2009;301(4):301–306. doi: 10.1007/s00403-009-0942-x.
62. Lamb J. The Connectivity Map: a new tool for biomedical research. Nature Reviews Cancer. 2007;7(1):54–60. doi: 10.1038/nrc2044.
63. Iorio F, Bosotti R, Scacheri E, et al. Discovery of drug mode of action and drug repositioning from transcriptional responses. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(33):14621–14626. doi: 10.1073/pnas.1000138107.
64. Hong Y, Downey T, Eu KW, Koh PK, Cheah PY. A ‘metastasis-prone’ signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clinical and Experimental Metastasis. 2010;27(2):83–90. doi: 10.1007/s10585-010-9305-4.
65. Huang P, Kishida S, Cao D, et al. The neuronal differentiation factor neuroD1 downregulates the neuronal repellent factor Slit2 expression and promotes cell motility and tumor formation of neuroblastoma. Cancer Research. 2011;71(8):2938–2948. doi: 10.1158/0008-5472.CAN-10-3524.
66. Fischer A, Sananbenesi F, Mungenast A, Tsai LH. Targeting the correct HDAC(s) to treat cognitive disorders. Trends in Pharmacological Sciences. 2010;31(12):605–617. doi: 10.1016/j.tips.2010.09.003.
67. Koch CM, Wagner W. Epigenetic-aging-signature to determine age in different tissues. Aging. 2011;3(10):1018–1027. doi: 10.18632/aging.100395.